TechNavio today launched its Stent Grafts Market in China 2011“2015 report based on an in-depth study exclusively focusing on China. The report aims to aid decision makers™ understanding of the present and the future landscape of the market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said, The Stent Grafts market in China is experiencing significant technological advancements in endovascular aortic repair (EVAR). EVAR has been proved to be a less-invasive substitute for conventional surgery in treating patients with abdominal aortic aneurysms and thoracic aortic aneurysms. Generally, endovascular procedures are preferred by both surgeons and patients because of the less invasive character of the treatments compared with open surgeries and because they shorten patients’ recovery period and decrease the mortality rate.
According to the report, the Stent Grafts market in China is experiencing an increase in the number of interventional cardiologists who are executing peripheral vascular intervention (PVI) on patients. Although PVI procedures were traditionally performed by interventional radiologists, there is an emerging trend of interventional cardiologists executing PVI procedures without referring patients to the radiology department.
The report also reveals that one of the major challenges in this market is the deterioration of metal stent grafts.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/stent-grafts-market-china-2011-2015
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report “ Stent Grafts Market in China 2011“2015
